Fabrizio Dolfi

Fabrizio Dolfi, MD, PhD, currently serves as the VP Head of Medical Affairs at Fresenius Kabi since February 2023. Previously, Fabrizio held the position of Senior Director Global Medical Affairs at Sobi - Swedish Orphan Biovitrum AB, focusing on rare diseases, CRS, and COVID-19. Fabrizio's expertise extends to consulting for pharmaceutical and biotech industries, contributing to clinical development strategies for atopic dermatitis at Arena Pharmaceuticals. Additional experience includes roles as Global Head of Medical Affairs and Promotional Compliance at Almirall, Franchise Medical Head for Immunology & Dermatology at Novartis, and Head of Clinical Development at Advanced Accelerator Applications. Preliminary roles involved leading medical affairs at NicOx and Galderma, as well as research positions at Sanford-Burnham Medical Research Institute and the University of California, San Diego. Education includes a Doctor of Philosophy in Molecular Biology and an MD in Medicine from Università degli Studi di Firenze.